Literature DB >> 32778942

Characterizing tau deposition in chronic traumatic encephalopathy (CTE): utility of the McKee CTE staging scheme.

Michael L Alosco1, Jonathan D Cherry1,2,3, Bertrand Russell Huber1,3,4, Yorghos Tripodis1,5, Zachary Baucom5, Neil W Kowall1,2,3, Nicole Saltiel1, Lee E Goldstein1,2,6,7,8,9, Douglas I Katz1,10, Brigid Dwyer1,10, Daniel H Daneshvar1, Joseph N Palmisano1,11, Brett Martin1,11, Robert C Cantu1,12,13,14, Robert A Stern1,12,15, Victor E Alvarez1,3,16, Jesse Mez1, Thor D Stein1,2,3,16, Ann C McKee17,18,19,20.   

Abstract

Chronic traumatic encephalopathy (CTE) is a tauopathy associated with repetitive head impacts (RHI) that has been neuropathologically diagnosed in American football players and other contact sport athletes. In 2013, McKee and colleagues proposed a staging scheme for characterizing the severity of the hyperphosphorylated tau (p-tau) pathology, the McKee CTE staging scheme. The staging scheme defined four pathological stages of CTE, stages I(mild)-IV(severe), based on the density and regional deposition of p-tau. The objective of this study was to test the utility of the McKee CTE staging scheme, and provide a detailed examination of the regional distribution of p-tau in CTE. We examined the relationship between the McKee CTE staging scheme and semi-quantitative and quantitative assessments of regional p-tau pathology, age at death, dementia, and years of American football play among 366 male brain donors neuropathologically diagnosed with CTE (mean age 61.86, SD 18.90). Spearman's rho correlations showed that higher CTE stage was associated with higher scores on all semi-quantitative and quantitative assessments of p-tau severity and density (p's < 0.001). The severity and distribution of CTE p-tau followed an age-dependent progression: older age was associated with increased odds for having a higher CTE stage (p < 0.001). CTE stage was independently associated with increased odds for dementia (p < 0.001). K-medoids cluster analysis of the semi-quantitative scales of p-tau across 14 regions identified 5 clusters of p-tau that conformed to increasing CTE stage (stage IV had 2 slightly different clusters), age at death, dementia, and years of American football play. There was a predilection for p-tau pathology in five regions: dorsolateral frontal cortex (DLF), superior temporal cortex, entorhinal cortex, amygdala, and locus coeruleus (LC), with CTE in the youngest brain donors and lowest CTE stage restricted to DLF and LC. These findings support the usefulness of the McKee CTE staging scheme and demonstrate the regional distribution of p-tau in CTE.

Entities:  

Keywords:  CTE stage; Chronic traumatic encephalopathy; McKee CTE staging scheme; Neurodegenerative disease; Repetitive head impacts; Traumatic brain injury

Mesh:

Substances:

Year:  2020        PMID: 32778942      PMCID: PMC7914059          DOI: 10.1007/s00401-020-02197-9

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  50 in total

Review 1.  Update on recent molecular and genetic advances in frontotemporal lobar degeneration.

Authors:  Eileen H Bigio
Journal:  J Neuropathol Exp Neurol       Date:  2008-07       Impact factor: 3.685

2.  Chronic traumatic encephalopathy pathology in a neurodegenerative disorders brain bank.

Authors:  Kevin F Bieniek; Owen A Ross; Kerry A Cormier; Ronald L Walton; Alexandra Soto-Ortolaza; Amelia E Johnston; Pamela DeSaro; Kevin B Boylan; Neill R Graff-Radford; Zbigniew K Wszolek; Rosa Rademakers; Bradley F Boeve; Ann C McKee; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2015-10-30       Impact factor: 17.088

3.  The aftermath of boxing.

Authors:  J A Corsellis; C J Bruton; D Freeman-Browne
Journal:  Psychol Med       Date:  1973-08       Impact factor: 7.723

4.  The central nervous system in motor neurone disease.

Authors:  B Brownell; D R Oppenheimer; J T Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-06       Impact factor: 10.154

5.  TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.

Authors:  Bryan D James; Robert S Wilson; Patricia A Boyle; John Q Trojanowski; David A Bennett; Julie A Schneider
Journal:  Brain       Date:  2016-11-01       Impact factor: 13.501

6.  Brainstem aminergic nuclei and late-life depressive symptoms.

Authors:  Robert S Wilson; Sukriti Nag; Patricia A Boyle; Loren P Hizel; Lei Yu; Aron S Buchman; Raj C Shah; Julia A Schneider; Steven E Arnold; David A Bennett
Journal:  JAMA Psychiatry       Date:  2013-12       Impact factor: 21.596

7.  Age of first exposure to tackle football and chronic traumatic encephalopathy.

Authors:  Michael L Alosco; Jesse Mez; Yorghos Tripodis; Patrick T Kiernan; Bobak Abdolmohammadi; Lauren Murphy; Neil W Kowall; Thor D Stein; Bertrand Russell Huber; Lee E Goldstein; Robert C Cantu; Douglas I Katz; Christine E Chaisson; Brett Martin; Todd M Solomon; Michael D McClean; Daniel H Daneshvar; Christopher J Nowinski; Robert A Stern; Ann C McKee
Journal:  Ann Neurol       Date:  2018-05       Impact factor: 10.422

8.  Cortical degeneration in chronic traumatic encephalopathy and Alzheimer's disease neuropathologic change.

Authors:  Richard A Armstrong; Ann C McKee; Thor D Stein; Victor E Alvarez; Nigel J Cairns
Journal:  Neurol Sci       Date:  2018-12-18       Impact factor: 3.307

9.  Association of White Matter Rarefaction, Arteriolosclerosis, and Tau With Dementia in Chronic Traumatic Encephalopathy.

Authors:  Michael L Alosco; Thor D Stein; Yorghos Tripodis; Alicia S Chua; Neil W Kowall; Bertrand Russell Huber; Lee E Goldstein; Robert C Cantu; Douglas I Katz; Joseph N Palmisano; Brett Martin; Jonathan D Cherry; Ian Mahar; Ronald J Killiany; Michael D McClean; Rhoda Au; Victor Alvarez; Robert A Stern; Jesse Mez; Ann C McKee
Journal:  JAMA Neurol       Date:  2019-11-01       Impact factor: 18.302

10.  Duration of American Football Play and Chronic Traumatic Encephalopathy.

Authors:  Jesse Mez; Daniel H Daneshvar; Bobak Abdolmohammadi; Alicia S Chua; Michael L Alosco; Patrick T Kiernan; Laney Evers; Laura Marshall; Brett M Martin; Joseph N Palmisano; Christopher J Nowinski; Ian Mahar; Jonathan D Cherry; Victor E Alvarez; Brigid Dwyer; Bertrand R Huber; Thor D Stein; Lee E Goldstein; Douglas I Katz; Robert C Cantu; Rhoda Au; Neil W Kowall; Robert A Stern; Michael D McClean; Jennifer Weuve; Yorghos Tripodis; Ann C McKee
Journal:  Ann Neurol       Date:  2019-11-23       Impact factor: 10.422

View more
  20 in total

1.  Reply: ATP10B and the risk for Parkinson's disease.

Authors:  Stefanie Smolders; Christine Van Broeckhoven
Journal:  Acta Neuropathol       Date:  2020-06-15       Impact factor: 17.088

2.  Association Between Antemortem FLAIR White Matter Hyperintensities and Neuropathology in Brain Donors Exposed to Repetitive Head Impacts.

Authors:  Madeline Uretsky; Sylvain Bouix; Ronald J Killiany; Yorghos Tripodis; Brett Martin; Joseph Palmisano; Asim Z Mian; Karen Buch; Chad Farris; Daniel H Daneshvar; Brigid Dwyer; Lee Goldstein; Douglas Katz; Christopher Nowinski; Robert Cantu; Neil Kowall; Bertrand Russell Huber; Robert A Stern; Victor E Alvarez; Thor D Stein; Ann McKee; Jesse Mez; Michael L Alosco
Journal:  Neurology       Date:  2021-11-24       Impact factor: 9.910

3.  Tau seeding in chronic traumatic encephalopathy parallels disease severity.

Authors:  Sarah K Kaufman; Sarah Svirsky; Jonathan D Cherry; Ann C McKee; Marc I Diamond
Journal:  Acta Neuropathol       Date:  2021-10-09       Impact factor: 17.088

4.  Differential Vulnerability of Hippocampal Subfields in Primary Age-Related Tauopathy and Chronic Traumatic Encephalopathy.

Authors:  Kurt Farrell; Megan A Iida; Jonathan D Cherry; Alicia Casella; Thor D Stein; Kevin F Bieniek; Jamie M Walker; Timothy E Richardson; Charles L White; Victor E Alvarez; Bertrand R Huber; Dennis W Dickson; Ricardo Insausti; Kristen Dams-O'Connor; Ann C McKee; John F Crary
Journal:  J Neuropathol Exp Neurol       Date:  2022-09-19       Impact factor: 3.148

5.  Differential gene expression in the cortical sulcus compared to the gyral crest within the early stages of chronic traumatic encephalopathy.

Authors:  Jonathan D Cherry; Filisia Agus; Erin Dixon; Bertrand Huber; Victor E Alvarez; Jesse Mez; Ann C McKee; Adam Labadorf; Thor D Stein
Journal:  Free Neuropathol       Date:  2021-08-17

6.  Associations between near end-of-life flortaucipir PET and postmortem CTE-related tau neuropathology in six former American football players.

Authors:  Michael L Alosco; Yi Su; Thor D Stein; Eric M Reiman; Ann C McKee; Robert A Stern; Hillary Protas; Jonathan D Cherry; Charles H Adler; Laura J Balcer; Charles Bernick; Surya Vamsi Pulukuri; Bobak Abdolmohammadi; Michael J Coleman; Joseph N Palmisano; Yorghos Tripodis; Jesse Mez; Gil D Rabinovici; Kenneth L Marek; Thomas G Beach; Keith A Johnson; Bertrand Russell Huber; Inga Koerte; Alexander P Lin; Sylvain Bouix; Jeffrey L Cummings; Martha E Shenton
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-09-24       Impact factor: 10.057

7.  Putative dendritic correlates of chronic traumatic encephalopathy: A preliminary quantitative Golgi exploration.

Authors:  Allysa Warling; Riri Uchida; Hyunsoo Shin; Coby Dodelson; Madeleine E Garcia; N Beckett Shea-Shumsky; Sarah Svirsky; Morgan Pothast; Hunter Kelley; Cynthia M Schumann; Christine Brzezinski; Melissa D Bauman; Allyson Alexander; Ann C McKee; Thor D Stein; Matthew Schall; Bob Jacobs
Journal:  J Comp Neurol       Date:  2020-09-23       Impact factor: 3.215

8.  ATP10B and the risk for Parkinson's disease.

Authors:  Raquel Real; Anni Moore; Cornelis Blauwendraat; Huw R Morris; Sara Bandres-Ciga
Journal:  Acta Neuropathol       Date:  2020-06-15       Impact factor: 17.088

Review 9.  Neuroimaging Biomarkers of Chronic Traumatic Encephalopathy: Targets for the Academic Memory Disorders Clinic.

Authors:  Michael L Alosco; Julia Culhane; Jesse Mez
Journal:  Neurotherapeutics       Date:  2021-04-13       Impact factor: 7.620

10.  Tau isoforms are differentially expressed across the hippocampus in chronic traumatic encephalopathy and Alzheimer's disease.

Authors:  Jonathan D Cherry; Camille D Esnault; Zachary H Baucom; Yorghos Tripodis; Bertrand R Huber; Victor E Alvarez; Thor D Stein; Dennis W Dickson; Ann C McKee
Journal:  Acta Neuropathol Commun       Date:  2021-05-12       Impact factor: 7.578

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.